News

Net Loss of Johnson Pharmacare reported to Rs 55.61 crore in the quarter ended March 2026 as against net loss of Rs 0.51 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net loss reported to Rs 55.73 crore in the year ended March 2026 as against net loss of Rs 0.58 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live News

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 27 May 2026.

Johnson Pharmacare has postponed the meeting of the Board of Directors which was scheduled to be held on 12 February 2026. The meeting will now be held on 14 February 2026.Powered by Capital Market - Live News

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News